+143.3%
MRNA vs NSC
+8.8%
+134.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | NSC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.4% | -2.0% | -2.2% |
| 7D | -10.1% | -2.0% | -8.0% | -8.5% |
| 30D | +126.7% | -3.2% | +129.9% | +138.0% |
| 3M | +184.1% | +3.9% | +180.2% | +205.7% |
| 6M | +143.3% | +7.8% | +135.5% | +165.0% |
| All | +143.3% | +8.8% | +134.5% | +165.0% |
Cumulative growth
Daily Returns
Daily percentage return beside NSC.
Daily Out/Under-Performance
Portfolio return minus NSC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NSC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded NSC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling